Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2018-08-09 Tx date 2018-05-04 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-166,734 vol |
27,789 | |
Filed 2018-08-08 Tx date 2018-08-08 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
52 - Expiration of options
|
-1,721 vol |
3,149 | |
Filed 2018-08-08 Tx date 2018-05-08 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-29,230 vol |
4,870 | |
Filed 2018-04-04 Tx date 2018-03-29 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,514.63
-4,366 vol $0.81 each |
194,523 | |
Filed 2018-03-16 Tx date 2018-02-22 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-225,154,800
-7,800 vol $28,866 each |
223,389 | |
Filed 2018-03-16 Tx date 2018-02-26 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,530
-7,000 vol $0.79 each |
216,389 | |
Filed 2018-03-16 Tx date 2018-02-28 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,530
-7,000 vol $0.79 each |
209,389 | |
Filed 2018-03-16 Tx date 2018-03-09 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,635
-7,000 vol $0.81 each |
202,389 | |
Filed 2018-03-16 Tx date 2018-03-12 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,250,000
-3,500 vol $3,500 each |
198,889 | |
Filed 2018-03-16 Tx date 2018-03-12 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$2,100
+2,500 vol $0.84 each |
34,100 | |
Filed 2018-02-19 Tx date 2017-06-26 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$169,696
+134,680 vol $1.26 each |
||
Filed 2018-02-19 Tx date 2017-06-26 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$169,696
+134,680 vol $1.26 each |
231,189 | |
Filed 2018-02-17 Tx date 2017-06-26 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$169,696
+134,680 vol $1.26 each |
231,189 | |
Filed 2017-12-12 Tx date 2017-04-09 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
52 - Expiration of options
|
$-78,400
-28,000 vol $2.80 each |
31,600 | |
Filed 2017-03-27 Tx date 2017-03-23 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$4,175
+2,500 vol $1.67 each |
59,600 | |
Filed 2016-12-21 Tx date 2016-12-21 |
$SBOT
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$5,074
+2,500 vol $2.03 each |
57,100 | |
Filed 2015-09-04 Tx date 2015-09-02 |
$KLH
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-868,585 vol |
96,509 | |
Filed 2015-09-04 Tx date 2015-09-02 |
$KLH
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-491,400 vol |
54,600 | |
Filed 2015-06-11 Tx date 2015-06-10 |
$KLH
Stellar Biotechnologies, Inc. |
Morse, Daniel E.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$22,250
+25,000 vol $0.89 each |
546,000 |